Sofwave for the neck: what the mid-dermal depth does for the submentum and neck lines

The neck is the second-highest-volume Sofwave-query region after the lower face, and the region where the FDA-clearance specifics matter most because the regulatory documentation explicitly names the submentum and the neck as indicated treatment areas. International patients arriving at consultation in Gangnam-area clinics often have a clearer picture of what they want — reduction of horizontal neck lines, mild lifting of the lax submentum, smoothing of upper neck texture — than they have for the lower face. The honest editorial read is that Sofwave addresses the neck well within the bounds of its mid-dermal depth, but those bounds matter: the platform addresses the dermal-quality dimension of neck laxity and the dermal architecture of horizontal neck lines, and does not address platysmal banding or the deeper structural laxity that produces more advanced patterns of neck descent. This guide walks through the FDA-clearance specifics for the neck indication, the way the 1.5 millimetre mid-dermal depth interacts with neck anatomy, the differences between addressing the submentum and the horizontal neck lines, the Gangnam-area protocol patterns senior physicians deploy, the realistic results trajectory, and the candidacy logic.

FDA clearance specifics: what the regulatory documentation actually says about the neck

The Sofwave FDA 510(k) clearance documentation is one of the clearest in the energy-based aesthetic platform category in naming the indicated treatment areas. The original 2019 clearance covered improvement of facial lines and wrinkles; subsequent clearance expansions added the indication for lifting the lax submentum and the neck, alongside the indication for improving the appearance of cellulite. The neck-and-submentum clearance is the regulatory anchor that distinguishes Sofwave from energy-based platforms whose clearance covers the face alone and whose neck use is off-label. The clinical consequence for international patients is that Sofwave's neck deployment in Korean clinics is on-label use under both the original FDA framework and the Korean Ministry of Food and Drug Safety clearance that mirrors the FDA indication. The marketing consequence is that clinic-marketing language can accurately describe Sofwave as cleared for neck tightening rather than relying on euphemisms or off-label-use language. For patients evaluating a clinic, the on-label-versus-off-label distinction is a small but real signal of regulatory-pathway integrity. The full clearance documentation is available through the FDA 510(k) database and is summarised in Sofwave Medical's regulatory page alongside the cleared-indication list.

The 1.5 millimetre depth and how neck anatomy responds to mid-dermal energy

Neck anatomy differs from facial anatomy in ways that matter for energy-based platform selection. The neck dermis is generally thinner than the facial dermis, the subcutaneous fat layer is thinner, the underlying platysmal sheet sits relatively superficially, and the major vasculature and nervous structures sit at well-defined depths that the operator must avoid. Sofwave's 1.5 millimetre mid-dermal targeting depth interacts well with neck anatomy specifically because the depth places the energy in the dermal layer without approaching the platysmal sheet and without approaching the carotid or jugular vasculature. The operator advances the handpiece in a methodical stripe pattern across the submentum, the anterior neck, and the lateral neck zones, with the depth calibrated to the neck's thinner dermal architecture. The clinical signature in the neck is a gradual dermal-quality improvement that produces softening of the horizontal neck lines and incremental tightening of the dermal-quality dimension of submental laxity over the three-to-six month dermal-remodelling window. The signature is not a platysmal-tightening signature — patients with visible platysmal banding will not see the bands resolve from Sofwave and require either a deeper-targeting approach or a surgical platysmaplasty consultation. The depth choice is the parameter that defines the candidate-selection logic for neck work, and the honest pre-consultation read is the same as for the jawline: dermal-quality candidates respond well, structural candidates need a different approach.

Submentum versus horizontal neck lines: two different treatment concerns

International patients often arrive at consultation with a single label — neck tightening — for what are clinically two distinguishable concerns that respond somewhat differently to Sofwave. The first concern is submental laxity: a soft or loose submental contour that may or may not include early jowl progression, with the dermal-quality dimension being the component Sofwave addresses. The second concern is horizontal neck lines: the etched horizontal creases that run across the anterior neck at various levels, driven by a combination of habitual neck flexion, dermal-quality decline, and in some patients photo-aged dermal texture. The submentum responds to Sofwave through gradual dermal tightening that incrementally improves the contour line over three to six months; the horizontal neck lines respond through dermal remodelling that softens the line depth and improves the line edge over the same window. Neither concern resolves dramatically; both improve incrementally. The Korean-market protocol pattern for patients with both concerns typically addresses both regions in a single Sofwave session, with the operator advancing through the submentum, the upper anterior neck where the higher horizontal lines sit, and the mid-anterior neck where the lower horizontal lines sit. The pricing for the combined neck protocol is moderately higher than the single-region protocol; the time investment is moderately longer; the candidacy logic is the same dermal-quality match across both concerns.

What the patient feels and what the recovery looks like on the neck

The patient-experience read for Sofwave on the neck is among the most tolerable in the energy-based platform category. Topical anaesthetic is applied to the treatment area for twenty to thirty minutes; the patient lies supine with the head extended; the operator advances the handpiece in stripes across the submentum and neck zones with each pulse producing a brief warm-pulse sensation lasting one to two seconds. Occasional pulses near the bony landmarks of the mandible at the submentum-neck junction produce a fleeting sharper sensation; the lateral-neck zones near the muscular landmarks are similarly mild. Oral analgesia is rarely needed; intravenous sedation is essentially never used. The post-treatment recovery on the neck is mild erythema for two to four hours, occasionally extending to six hours in patients with reactive skin, with no swelling pattern of consequence and no bruising risk in the typical case. The patient can drive home immediately, return to work the same day, and fly back to Singapore or Hong Kong the following day. The recovery profile is one of the operational advantages that has made Sofwave attractive to international patients on tight Korea-trip schedules — the platform produces a meaningful dermal-remodelling outcome without a recovery window that complicates flight planning or business commitments.

Where Sofwave sits within Korean Gangnam-area neck-treatment protocols

Gangnam-area senior physicians deploy Sofwave for neck work within a handful of well-defined protocol patterns. The first and most common is the dermal-quality-focused neck protocol: a patient with horizontal neck lines and mild submental dermal laxity receives a single Sofwave session covering the full neck zone, with results assessed at the three-month and six-month follow-up. The second pattern is the combined face-and-neck protocol where Sofwave addresses both regions in a single session, with pricing and time investment scaled accordingly. The third pattern is the multi-modality neck protocol where Sofwave addresses the dermal-quality dimension and a separate modality — biostimulator injectables for dermal scaffolding, radiofrequency microneedling for textural concerns, or a deeper-targeting ultrasound platform for the SMAS-and-platysma dimension — addresses an adjacent dimension. The dominant Korean-market practice is to be honest about platform scope; patients with platysmal banding are typically referred for a different conversation rather than offered Sofwave as a solution for an indication it does not address. The Korea Health Industry Development Institute publishes practice-pattern data for the medical-tourism segment.

Results trajectory on the neck and what realistic expectation looks like

Sofwave's neck results signature follows the same gradual three-to-six month build observed at other facial-and-cervical treatment zones, with the patient leaving the clinic looking identical to baseline and seeing peak result at the three-to-six month follow-up window. Subtle improvement in the horizontal neck lines and in the submental contour begins around four to eight weeks; the dermal-remodelling signature matures over three to six months as the collagen-and-elastin architecture reorganises. The realistic-expectation read is that the horizontal neck lines soften but do not disappear, the submental contour tightens incrementally but does not transform, and the overall neck quality improves in a way that produces a younger-looking neck profile without producing a dramatic before-and-after change. Patients who arrive expecting a dramatic transformation will be disappointed; patients who arrive expecting incremental dermal-quality improvement will be satisfied. A second Sofwave neck session at the six-month or twelve-month interval is a common protocol pattern for patients whose response to the first session is modest, with the senior physician's six-month follow-up assessment determining cadence. Comparative neck-treatment context across surgical and non-surgical modalities is available through the American Academy of Dermatology patient-resource library and worth reading alongside the manufacturer documentation.

Frequently asked questions

Is Sofwave FDA-cleared specifically for the neck?

Yes. Sofwave holds FDA 510(k) clearance that includes the indication for lifting the lax submentum and the neck, in addition to the original facial-lines-and-wrinkles indication. The neck-and-submentum clearance is an explicit on-label indication rather than off-label use. Korean Ministry of Food and Drug Safety clearance mirrors the FDA indication for use in authorised Korean clinics.

Will Sofwave remove my horizontal neck lines?

Sofwave softens the depth and improves the edge quality of horizontal neck lines through dermal remodelling; it does not erase them. Patients with shallow-to-moderate horizontal neck lines see meaningful improvement; patients with deeply etched lines see partial improvement that may be combined with injectable-based approaches for the deeper line components. The realistic expectation is incremental softening rather than disappearance.

Can Sofwave fix neck bands?

No. Visible platysmal banding is driven by underlying muscle architecture that Sofwave does not address. Patients with platysmal banding require either neuromodulator injection of the platysmal bands, deeper-targeting ultrasound, or a surgical platysmaplasty consultation. A senior physician will be honest about this scope limitation at consultation.

How much submental tightening can I realistically expect?

Mild to moderate dermal-quality tightening that improves the submental contour line incrementally over three to six months. The improvement is meaningful for early-laxity candidates whose submental concern is dermal rather than structural; the improvement is modest for candidates whose submental laxity has progressed into the deeper layers. The candidacy-match question is the determining factor.

Does the neck require more or fewer pulses than the lower face?

The neck protocol typically uses a comparable pulse density to the lower face on a per-unit-area basis, with the total pulse count scaled to the treatment-area dimensions. The operator's pulse-count discipline matters — under-pulsing the neck produces a weaker dermal-remodelling outcome regardless of platform authenticity. Patients should ask about pulse count at consultation and be wary of substantially under-priced neck protocols.

How long is a Sofwave neck session?

A neck-only Sofwave protocol typically runs twenty-five to forty-five minutes from skin preparation to handpiece-down; a combined neck-and-face protocol runs forty-five to seventy-five minutes. The patient should plan for approximately ninety minutes total clinic time including pre-treatment topical anaesthetic application and post-treatment cool-down.

When will I see neck results from Sofwave?

Subtle improvement appears around four to eight weeks; peak result at three to six months as dermal collagen-and-elastin remodelling matures. There is no immediate post-treatment change on the neck — the patient leaves looking identical to baseline. Patients who need visible improvement for an event within four weeks are not good Sofwave candidates.

Can I treat the chest and decolletage in the same session?

Yes, in some cases. Korean clinics commonly combine Sofwave neck treatment with decolletage-area dermal-quality work in a single extended session for patients whose dermal-quality concerns span the cervical-to-upper-chest region. The senior physician will assess candidacy and recommend whether the combined protocol is appropriate; the pricing and time investment scale accordingly.